Jeroen Dekervel

Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer

Scott Kopetz, Axel Grothey, Rona Yaeger et al. · New England Journal of Medicine · 2019 · 1.4K citations · Full text

Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth

Hannah van Malenstein, Jeroen Dekervel, Chris Verslype et al. · Cancer Letters · 2012 · 189 citations

Hepatocellular Carcinoma, Medicine, Liver Physiology +12

Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching

Linde De Smedt, Sofie Palmans, Daan Andel et al. · British Journal of Cancer · 2016 · 163 citations · Full text

DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer

Eva Galle, Bernard Thienpont, Sarah Cappuyns et al. · Clinical Epigenetics · 2020 · 96 citations · Full text

[18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients

Elin Pauwels, Frederik Cleeren, Térence Tshibangu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 88 citations

Positron Emission Tomography, Engineering, Oncologic Imaging +11